Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
about
15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survivalPolyunsaturated fatty acid metabolism in prostate cancerMechanisms of omega-3 polyunsaturated fatty acids in prostate cancer preventionAre all n-3 polyunsaturated fatty acids created equal?Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acidsA review of the biologic and pharmacologic role of docosapentaenoic acid n-3Arachidonic acid metabolism in human prostate cancer15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cellsOmega-3 Fatty Acids and PPARgamma in CancerStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerFatty acid synthase is required for mammary gland development and milk production during lactationHepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI.The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer.Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System.Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigeneticsOmega-3 fatty acids, genetic variants in COX-2 and prostate cancer.An Ω-3 fatty acid desaturase-expressing gene attenuates prostate cancer proliferation by cell cycle regulationDietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.Abundance of active ingredients in sea-buckthorn oilTreatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung.Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury.Dietary supplementation of α-linolenic acid induced conversion of n-3 LCPUFAs and reduced prostate cancer growth in a mouse model.A high omega-3 fatty acid diet mitigates murine pancreatic precancer development.Endogenous synthesis of n-3 polyunsaturated fatty acids in Fat-1 mice is associated with increased mammary gland and liver syndecan-1.Effects of dietary fish oil on the depletion of carcinogenic PAH-DNA adduct levels in the liver of B6C3F1 mouse.Molecular genetics of prostate cancer: new prospects for old challengesSyndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancerEssential fatty acids as functional components of foods- a reviewThe use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentInhibiting delta-6 desaturase activity suppresses tumor growth in mice.Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice.New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKOmega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathwayRaman microspectroscopy of noncancerous and cancerous human breast tissues. Identification and phase transitions of linoleic and oleic acids by Raman low-temperature studies.Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice.A high-fat diet containing lard accelerates prostate cancer progression and reduces survival rate in mice: possible contribution of adipose tissue-derived cytokinesPhase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.
P2860
Q21134042-7C646306-63D8-4F77-9845-95DDC8D060AFQ24629893-609D11E8-77FE-4DFA-8DC6-F706EA010863Q26830150-8BDD02BF-555C-4BFA-ACAA-A8CD5B2239EFQ27497371-BC396790-CD48-480A-98E5-87493C1AB6DBQ28076327-2C5C4F6F-535B-41EF-A0DF-380098D90F32Q28248251-51495393-B423-46C6-B566-6A7DA355011AQ28273154-A6681681-B92F-47D9-930C-C27AADF52FADQ28277101-C85DDB54-13DF-4EDE-88B7-69670307A488Q28292907-4F65F3DC-E8EB-47F8-B181-CDD6CF82CAB9Q28304230-2D2DA4BE-7840-41BA-AA0F-D524D8B47B20Q28584871-9D8E5B7E-1720-406A-8C67-A0438DA76B4AQ30488507-0BE97A8B-4300-4106-A7F9-B2EDF707213AQ30500308-52D33A96-0627-442D-B26E-A1899B0432BFQ32179802-1E735FF6-16D4-4AE3-82FD-2FED69125833Q33564264-E0880631-F13C-420F-961A-81DDB92106C8Q33647546-8E2BD391-447F-4A89-BB8E-7CDB42F97E9BQ33647551-29D8A31A-F8F7-4B3C-8593-0CAEC62644B7Q33684875-4E4F96DD-8ED2-4924-A405-E23E16D7F824Q33705232-0D286A57-FAE3-47B1-81E2-5A8C214ED0A3Q33709097-21B3D5C8-A117-4739-A80C-997A7DD4B3C7Q33798656-A0A9ABDC-F855-4F8B-AEE3-9CC08AEAC9D4Q33825080-425EE016-6955-4BDB-94E4-25B0491A09ADQ33893626-C568C3AB-6C01-4F48-A5B5-059A5BEA87A3Q33925530-9258ADB0-6720-4360-B745-D73460E6F700Q33927026-C4AE6903-A044-4A72-A30D-C4EFB66DBE74Q34069595-5959C88B-D132-4CA0-9278-F0A7A99F2D7FQ34127462-AEFEAAE5-DFE2-427D-AFAC-6B21C6EFBCAEQ34177237-7E223FC7-31F7-4D77-A11B-14805006E059Q34308540-58FBAD02-C943-4954-BE32-708E0DEA6378Q34411758-423A71AF-65D9-4EA6-A470-0AE7DF2C8E58Q34462192-4D049E03-CFFF-423C-8611-D77F23A388FAQ34591316-7461C03F-D6D5-42A8-A117-73E20236CCD7Q34705022-5BA7FF16-499A-4AC5-9BCD-51E2C3F98F39Q35222084-C8B8A5A0-D698-4A6D-AE30-8BA6958C44BEQ35230305-60B61B7F-BCA4-489E-AA3F-14E187E36A6DQ35568742-4A6C34F6-EFD7-4DE5-818C-4CCF72EA2AEFQ35574980-E38AC3CE-ECE0-4F82-9BEC-DDCEE883DA04Q35585932-6130E96E-6679-459C-AF37-2B9D27861897Q35597212-D95D1D42-1B6D-4217-A7D3-B6D630BB7A1DQ35641491-9387B4EE-E0D2-46DD-A6B1-3B2D54D9E530
P2860
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@ast
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@en
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@nl
type
label
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@ast
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@en
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@nl
prefLabel
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@ast
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@en
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@nl
P2093
P2860
P356
P1476
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
@en
P2093
Adrienne Smith
Donna Perry
George Kulik
Iris J Edwards
Isabelle M Berquin
J Mark Cline
Jiansheng Wu
Jing X Kang
P2860
P304
P356
10.1172/JCI31494
P407
P577
2007-07-01T00:00:00Z